Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

BACKGROUND: Vaccination with a recombinant modified vaccinia Ankara expressing antigen 85A from Mycobacterium tuberculosis, MVA85A, induces high levels of cellular immune responses in UK volunteers. We assessed the safety and immunogenicity of this new vaccine in West African volunteers. METHODS AND...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Brookes, Roger H., Hill, Philip C., Owiafe, Patrick K., Ibanga, Hannah B., Jeffries, David J., Donkor, Simon A., Fletcher, Helen A., Hammond, Abdulrahman S., Lienhardt, Christian, Adegbola, Richard A., McShane, Helen, Hill, Adrian V. S.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2008
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2488375/
https://ncbi.nlm.nih.gov/pubmed/18698342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0002921
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares